Cancer Archives - Wiser Healthcare

Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review – Smriti Raichand et al.

Lucia Marcello2024-07-30T15:47:29+10:00Breast cancer, Breast density, Cancer, Imaging, Publications, Screening, Women's health|

Digital breast tomosynthesis (DBT) may improve sensitivity in population screening. However, evidence is currently limited on the performance of DBT in patients at a higher risk of breast cancer. This systematic review compares the clinical effectiveness and cost-effectiveness of DBT, digital mammography (DM), and ultrasound, [...]

Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia – Daniel Lindsay et al.

Lucia Marcello2024-07-30T15:40:18+10:00Cancer, Melanoma, Overdiagnosis, Overtreatment, Publications, Risk|

Research suggests a high proportion of melanoma in situ (MIS) may be overdiagnosed, potentially contributing to overtreatment, patient harm and inflated costs for individuals and healthcare systems. However, Australia-wide estimates of the magnitude of melanoma overdiagnosis are potentially outdated and there has been no estimation of the [...]

Factors associated with private or public breast cancer screening attendance in Queensland, Australia: A retrospective cross-sectional study – Tong Li et al.

Lucia Marcello2024-07-30T12:16:47+10:00Breast cancer, Cancer, Publications, Screening, Women's health|

This study aimed to estimate participation in private breast screening in Queensland, Australia, where public-funded screening is implemented, and to identify factors associated with the screening setting, using an online survey (999 female respondents aged 40-74). Screening-specific and socio-demographic factors were collected. Multivariable logistic regression [...]

Mammography Screening Preferences Among Screening-Eligible Women in Their 40s : A National U.S. Survey – Laura D Scherer et al.

Lucia Marcello2024-07-30T12:06:55+10:00Breast cancer, Cancer, Decision aids, Publications, Screening, Shared decision making, Women's health|

The U.S. Preventive Services Task Force (USPSTF) recently changed its recommendation for mammography screening from informed decision making to biennial screening for women aged 40 to 49 years. Although many women welcome this change, some may prefer not to be screened at age 40 years. [...]

Breast cancer screening from age 40 in the US – Katy JL Bell et al.

Lucia Marcello2024-07-30T11:45:58+10:00Breast cancer, Cancer, Health policy, Overdiagnosis, Publications, Risk, Screening, Women's health|

The US Preventive Services Task Force has updated its recommendation for the age when all women should start mammography screening, lowering it from 50 to 40. This change immediately affects more than 20 million American women and other people assigned female at birth who are [...]

Frequency and characteristics of errors by artificial intelligence (AI) in reading screening mammography: a systematic review – Aileen Zeng et al.

Lucia Marcello2024-07-30T10:02:38+10:00AI, Breast cancer, Cancer, Publications, Screening|

Artificial intelligence (AI) for reading breast screening mammograms could potentially replace (some) human-reading and improve screening effectiveness. This systematic review aims to identify and quantify the types of AI errors to better understand the consequences of implementing this technology.

Congratulations to Prof Adam Elshaug elected as Australia’s member of the Scientific Council of the International Agency for Research on Cancer, WHO!

Krista Verlis2024-07-29T14:19:27+10:00Awards, Cancer, News|

At the 66th Session of the WHO/IARC Governing Council, held on 15–16 May 2024 Professor Adam Elshaug was elected as Australia’s representative member of the Scientific Council (SC) of the International Agency for Research on Cancer (IARC), for a four-year term. The principal responsibilities of [...]

The Conversation – Breast cancer screening in Australia may change. Here’s what we know so far

Krista Verlis2024-07-29T14:08:30+10:00Breast cancer, News, Screening, Women's health|

The way women are screened for breast cancer in Australia may change. There’s international debate on the age women should be invited for screening. But an even larger change being considered worldwide is whether to screen women at high and low risk of breast cancer differently. But what such a [...]

Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma – Deonna M. Ackermann et al.

Lucia Marcello2024-06-04T12:14:37+10:00Cancer, Clinical trials, Melanoma, Patient-led surveillance, Publications, Randomised Control Trial (RCT), Research|

Adherence to self-management interventions is critical in both clinical settings and trials to ensure maximal effectiveness. This study reports how the Behaviour Change Wheel may be used to assess barriers to self-management behaviours and develop strategies to maximise adherence in a trial setting (the MEL-SELF [...]

The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study – Bianka D’souza et al.

Lucia Marcello2024-06-04T12:12:34+10:00Cancer, COVID-19, Publications, Thyroid cancer, Treatment|

The ongoing coronavirus (COVID-19) pandemic has led to a global public health response. In Australia, an increased burden on the healthcare system and resource needs resulted in non-urgent elective surgery being postponed from March 2020. In response to COVID-19 case numbers, there was varying easing and tightening [...]

Cancer

Staff Intranet